ATTD: Advanced Technologies and Treatments for Diabetes

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.

ATTD: Advanced Technologies and Treatments for Diabetes is a science podcast hosted by ATTD on UNLOK, with 76 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

ATTD on UNLOK hosts ATTD: Advanced Technologies and Treatments for Diabetes, a science show with 76 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  ATTD: Advanced Technologies and Treatments for Diabetes

  Overcoming therapeutic inertia with inhaled insulin

  Aug 11, 202617 min

  In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation. Key discussion points: Defining therapeutic inertia in the context of insulin initiation. Common clinician and patient-related barriers that contribute to treatment delays. Practical strategies for introducing inhaled insulin to hesitant patients. System-level considerations, including workflow and reimbursement challenges. Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/ Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together. #DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcast Chapters: 00:00 Why Inhaled Insulin Matters 00:34 Show Intro and Guest 01:22 Defining Therapeutic Inertia 02:19 Clinician Barriers to Insulin 03:49 Patient Fears and Hesitation 05:28 How Inhaled Insulin Helps 07:00 Best Fit Patient Scenarios 08:22 Talking to Hesitant Patients 10:39 Workflow and Coverage Hurdles 13:35 PFT Testing and Side Effects 14:47 Future Role and Wrap Up

  ListenShow Notes
• 

  ATTD: Advanced Technologies and Treatments for Diabetes

  Addressing Clinicians’ FAQs on Insulin Therapy

  Jul 28, 202617 min

  In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy. They discuss: The most common mistakes or misconceptions in basal insulin initiation and management Intensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinations Leveraging technologies to improve insulin adherence and outcomes Managing hypoglycemia concerns and achieving glycemic targets Addressing psychological and behavioral barriers to insulin use in everyday clinical practice Dr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

  ListenShow Notes
• 

  ATTD: Advanced Technologies and Treatments for Diabetes

  Personalised Approaches for Complex Populations

  Jul 14, 202614 min

  In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations. They discuss: Why personalization is particularly important in insulin therapy The patient groups most in need of a tailored approach How comorbidities or frailty influence insulin decision-making Guidelines, flexibility, and local solutions Dr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

  ListenShow Notes
• 

  ATTD: Advanced Technologies and Treatments for Diabetes

  Overcoming Barriers to Insulin Adherence

  Jun 30, 202618 min

  In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients. They discuss: The barriers most misunderstood by clinicians Communication and motivational interviewing with patients Emotional burden and fear of hypoglycemia Practical strategies clinicians can use to support patients more effectively The role of the wider diabetes healthcare team Diana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

  ListenShow Notes
• 

  ATTD: Advanced Technologies and Treatments for Diabetes

  Preventing & Managing Hypoglycemia

  Jun 16, 202619 min

  In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education. They discuss: Why hypoglycemia remains a major concern in insulin therapy Key risk factors to keep in mind Clinical signs or patient-reported symptoms Prevention strategies Importance of patient education Balancing glycemic targets with hypoglycemia risk Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

  ListenShow Notes

Recent guests on ATTD: Advanced Technologies and Treatments for Diabetes. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.